{
  "national_weighted_loss_per_fill": 52.16,
  "methodology": "Structural loss = NADAC acquisition cost - PBM reimbursement. PBMs reimburse ~96.5% of NADAC on GLP-1s (3.5% underwater). Based on NCPA survey data showing $42/fill avg loss on ~$1000 acquisition (~4.2% underwater). We use conservative 3.5% estimate. Weighted by CMS Part D prescribing volume (national and per-state drug mix). NADAC source: data.medicaid.gov (weekly pharmacy acquisition costs). Note: actual pharmacy acquisition costs vary by wholesaler contract, GPO membership, and volume. NADAC is a national average. Reimbursement varies by PBM contract.",
  "data_sources": {
    "nadac": "data.medicaid.gov NADAC (National Average Drug Acquisition Cost)",
    "prescribing_volume": "CMS Part D Prescribers by Provider and Drug",
    "reimbursement_ratio": 0.965,
    "underwater_pct": "3.5%"
  },
  "per_drug": {
    "semaglutide": {
      "nadac_per_unit": 639.138,
      "units_per_fill": 3.0,
      "acquisition_per_fill": 1917.41,
      "reimbursement_ratio": 0.965,
      "est_reimbursement_per_fill": 1850.3,
      "structural_loss_per_fill": 67.11,
      "brand_name": "OZEMPIC 0.25-0.5 MG/DOSE (2 MG/1.5 ML) PEN",
      "effective_date": "2025-01-01",
      "national_claims_pct": 49.2
    },
    "tirzepatide": {
      "nadac_per_unit": 521.005,
      "units_per_fill": 2.4,
      "acquisition_per_fill": 1250.41,
      "reimbursement_ratio": 0.965,
      "est_reimbursement_per_fill": 1206.65,
      "structural_loss_per_fill": 43.76,
      "brand_name": "MOUNJARO 10 MG/0.5 ML PEN",
      "effective_date": "2025-01-01",
      "national_claims_pct": 11.2
    },
    "liraglutide": {
      "nadac_per_unit": 86.8161,
      "units_per_fill": 18.0,
      "acquisition_per_fill": 1562.69,
      "reimbursement_ratio": 0.965,
      "est_reimbursement_per_fill": 1508.0,
      "structural_loss_per_fill": 54.69,
      "brand_name": "SAXENDA 18 MG/3 ML PEN",
      "effective_date": "2025-02-19",
      "national_claims_pct": 5.7
    },
    "dulaglutide": {
      "nadac_per_unit": 476.4099,
      "units_per_fill": 2.0,
      "acquisition_per_fill": 952.82,
      "reimbursement_ratio": 0.965,
      "est_reimbursement_per_fill": 919.47,
      "structural_loss_per_fill": 33.35,
      "brand_name": "TRULICITY 0.75 MG/0.5 ML PEN",
      "effective_date": "2025-01-01",
      "national_claims_pct": 32.5
    },
    "exenatide": {
      "nadac_per_unit": 234.2888,
      "units_per_fill": 2.4,
      "acquisition_per_fill": 562.29,
      "reimbursement_ratio": 0.965,
      "est_reimbursement_per_fill": 542.61,
      "structural_loss_per_fill": 19.68,
      "brand_name": "BYDUREON BCISE 2 MG AUTOINJECT",
      "effective_date": "2025-02-19",
      "national_claims_pct": 1.4
    }
  },
  "per_state": {
    "AK": {
      "weighted_loss_per_fill": 55.7,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 58.7
    },
    "AL": {
      "weighted_loss_per_fill": 52.24,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 47.2
    },
    "AR": {
      "weighted_loss_per_fill": 53.85,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.0
    },
    "AZ": {
      "weighted_loss_per_fill": 51.38,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 46.8
    },
    "CA": {
      "weighted_loss_per_fill": 53.36,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 53.3
    },
    "CO": {
      "weighted_loss_per_fill": 49.25,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 39.5
    },
    "CT": {
      "weighted_loss_per_fill": 53.95,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 54.9
    },
    "DC": {
      "weighted_loss_per_fill": 49.34,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 44.6
    },
    "DE": {
      "weighted_loss_per_fill": 52.22,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.0
    },
    "FL": {
      "weighted_loss_per_fill": 53.13,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 53.1
    },
    "GA": {
      "weighted_loss_per_fill": 53.22,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.4
    },
    "HI": {
      "weighted_loss_per_fill": 54.67,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 57.1
    },
    "IA": {
      "weighted_loss_per_fill": 54.48,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 56.7
    },
    "ID": {
      "weighted_loss_per_fill": 52.91,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.6
    },
    "IL": {
      "weighted_loss_per_fill": 52.46,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 50.3
    },
    "IN": {
      "weighted_loss_per_fill": 51.61,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 46.6
    },
    "KS": {
      "weighted_loss_per_fill": 53.31,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.3
    },
    "KY": {
      "weighted_loss_per_fill": 53.29,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.9
    },
    "LA": {
      "weighted_loss_per_fill": 51.39,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 45.0
    },
    "MA": {
      "weighted_loss_per_fill": 45.81,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 56.8
    },
    "MD": {
      "weighted_loss_per_fill": 51.69,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 49.5
    },
    "ME": {
      "weighted_loss_per_fill": 49.04,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 44.3
    },
    "MI": {
      "weighted_loss_per_fill": 48.82,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 42.6
    },
    "MN": {
      "weighted_loss_per_fill": 53.19,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 50.5
    },
    "MO": {
      "weighted_loss_per_fill": 52.53,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 49.0
    },
    "MS": {
      "weighted_loss_per_fill": 54.93,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 56.3
    },
    "MT": {
      "weighted_loss_per_fill": 52.55,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 48.6
    },
    "NC": {
      "weighted_loss_per_fill": 54.13,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 54.9
    },
    "ND": {
      "weighted_loss_per_fill": 55.79,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 57.4
    },
    "NE": {
      "weighted_loss_per_fill": 50.98,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 45.7
    },
    "NH": {
      "weighted_loss_per_fill": 50.68,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 44.2
    },
    "NJ": {
      "weighted_loss_per_fill": 52.52,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.2
    },
    "NM": {
      "weighted_loss_per_fill": 49.18,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 43.3
    },
    "NV": {
      "weighted_loss_per_fill": 52.79,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.3
    },
    "NY": {
      "weighted_loss_per_fill": 52.47,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.6
    },
    "OH": {
      "weighted_loss_per_fill": 49.14,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 41.8
    },
    "OK": {
      "weighted_loss_per_fill": 53.33,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 51.6
    },
    "OR": {
      "weighted_loss_per_fill": 51.55,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 47.3
    },
    "PA": {
      "weighted_loss_per_fill": 50.34,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 44.6
    },
    "RI": {
      "weighted_loss_per_fill": 50.21,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 45.9
    },
    "SC": {
      "weighted_loss_per_fill": 52.41,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 49.1
    },
    "SD": {
      "weighted_loss_per_fill": 55.75,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 59.7
    },
    "TN": {
      "weighted_loss_per_fill": 53.47,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 53.3
    },
    "TX": {
      "weighted_loss_per_fill": 53.78,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 53.9
    },
    "UT": {
      "weighted_loss_per_fill": 48.77,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 40.8
    },
    "VA": {
      "weighted_loss_per_fill": 50.45,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 44.6
    },
    "VT": {
      "weighted_loss_per_fill": 52.53,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 50.2
    },
    "WA": {
      "weighted_loss_per_fill": 53.33,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 49.4
    },
    "WI": {
      "weighted_loss_per_fill": 48.42,
      "dominant_drug": "dulaglutide",
      "dominant_drug_pct": 46.1
    },
    "WV": {
      "weighted_loss_per_fill": 53.23,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 52.4
    },
    "WY": {
      "weighted_loss_per_fill": 52.61,
      "dominant_drug": "semaglutide",
      "dominant_drug_pct": 49.4
    }
  }
}